Details of the Drug
General Information of Drug (ID: DMFGLXB)
| Drug Name |
Phensuximide
|
||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
Phensuximide; Milontin; Succitimal; Lifene; Phenylsuximide; Epimid; Fensuccimide; Fenosuccimide; Phensuximidum; 86-34-0; phensuccimide; Fensuximida; Phensuximid; Methylphenylsuccinimide; Fensuccimide [DCIT]; Succinimide, N-methyl-2-phenyl-; Phensuximidum [INN-Latin]; Fensuximida [INN-Spanish]; 1-methyl-3-phenylpyrrolidine-2,5-dione; Mirontin; Milonton; N-Methyl-alpha-phenylsuccinimide; PM 334; N-Methyl-2-phenylsuccinimide; Milontin (TN); 1-Methyl-3-phenylpyrrolidin-2,5-dione; 1-Methyl-3-phenyl-2,5-pyrrolidinedione; EINECS 201-664-6
|
||||||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||||||
| Affected Organisms |
Humans and other mammals
|
||||||||||||||||||||||||||
| ATC Code | |||||||||||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||||||
| Drug-Molecule Activity Atlas (DMA)NEW | Click to Jump to the Detailed DMA Information of This Drug | ||||||||||||||||||||||||||
| Drug Pharmacogenomic Perturbation (DPP)NEW | Click to Jump to the Detailed DPP Information of This Drug | ||||||||||||||||||||||||||
| Drug ADMET Endpoint Profile (DAE)NEW | Click to Jump to the Detailed DAE Information of This Drug | ||||||||||||||||||||||||||
| Combinatorial Drugs (CBD) | Click to Jump to the Detailed CBD Information of This Drug | ||||||||||||||||||||||||||
| Repurposed Drugs (RPD) | Click to Jump to the Detailed RPD Information of This Drug | ||||||||||||||||||||||||||

